U S PHYSICAL THERAPY INC /NV (USPH) Gross Margin
- Gross margin · 12 months: Value 18.68%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 18.68% | Gross profit / revenue. Period ending 2026-06-30. $151.70M ÷ $812.20M × 100 ≈ 18.68% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 151.70M USD | Gross Profit |
| Revenue | 812.20M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $151.70M | $812.20M | (m) | 18.68% |
| 2026-03-31 | $151.38M | $795.49M | (m) | 19.03% |
| 2025-12-31 | $149.69M | $780.99M | (m) | 19.17% |
| 2025-09-30 | $142.09M | $758.71M | (m) | 18.73% |
| 2025-06-30 | $134.35M | $729.61M | (m) | 18.41% |
| 2025-03-31 | $126.58M | $699.46M | (m) | 18.10% |
| 2024-12-31 | $123.92M | $671.35M | (m) | 18.46% |
| 2024-09-30 | $121.91M | $645.70M | (m) | 18.88% |
| 2024-06-30 | $120.71M | $627.67M | (m) | 19.23% |
| 2024-03-31 | $119.05M | $611.97M | (m) | 19.45% |
| 2023-12-31 | $121.51M | $604.80M | (m) | 20.09% |
| 2023-09-30 | $118.82M | $591.18M | (m) | 20.10% |
| 2023-06-30 | $117.68M | $580.78M | (m) | 20.26% |
| 2023-03-31 | $116.29M | $569.95M | (m) | 20.40% |
| 2022-12-31 | $112.02M | $553.14M | (m) | 20.25% |
| 2022-09-30 | $111.38M | $541.79M | (m) | 20.56% |
| 2022-06-30 | $114.39M | $528.09M | (m) | 21.66% |
| 2022-03-31 | $117.87M | $514.36M | (m) | 22.92% |
| 2021-12-31 | $117.18M | $495.02M | (m) | 23.67% |
| 2021-09-30 | $119.12M | $482.65M | (m) | 24.68% |
| 2021-06-30 | $119.67M | $465.69M | (m) | 25.70% |
| 2021-03-31 | $104.66M | $422.62M | (m) | 24.76% |
| 2020-12-31 | $94.45M | $422.97M | (m) | 22.33% |
| 2020-09-30 | $92.29M | $427.62M | (m) | 21.58% |
| 2020-06-30 | $89.31M | $435.94M | (m) | 20.49% |
| 2020-03-31 | $101.45M | $478.45M | (m) | 21.20% |
| 2019-12-31 | $112.47M | $481.97M | (m) | 23.34% |
| 2019-09-30 | $110.73M | $477.20M | (m) | 23.20% |
| 2019-06-30 | $109.44M | $473.07M | (m) | 23.13% |
| 2019-03-31 | $105.17M | $461.80M | (m) | 22.77% |
| 2018-12-31 | $101.66M | $453.91M | (m) | 22.40% |
| 2018-09-30 | $100.59M | $445.76M | (m) | 22.57% |
| 2018-06-30 | $95.70M | $435.68M | (m) | 21.97% |
| 2018-03-31 | $93.08M | $424.83M | (m) | 21.91% |
| 2017-12-31 | $90.62M | $414.05M | (m) | 21.89% |
| 2017-09-30 | $85.27M | $395.71M | (m) | 21.55% |
| 2017-06-30 | $83.74M | $381.02M | (m) | 21.98% |
| 2017-03-31 | $82.26M | $367.20M | (m) | 22.40% |
| 2016-12-31 | $82.01M | $356.55M | (m) | 23.00% |
| 2016-09-30 | $84.72M | $352.41M | (m) | 24.04% |
| 2016-06-30 | $83.93M | $348.11M | (m) | 24.11% |
| 2016-03-31 | $82.01M | $340.97M | (m) | 24.05% |
| 2015-12-31 | $78.36M | $331.30M | (m) | 23.65% |
| 2015-09-30 | $75.80M | $323.97M | (m) | 23.40% |
| 2015-06-30 | $75.67M | $317.63M | (m) | 23.82% |
| 2015-03-31 | $76.36M | $312.55M | (m) | 24.43% |
| 2014-12-31 | $76.17M | $305.07M | (m) | 24.97% |
| 2014-09-30 | $73.36M | $294.29M | (m) | 24.93% |
| 2014-06-30 | $70.75M | $282.40M | (m) | 25.05% |
| 2014-03-31 | $66.50M | $271.07M | (m) | 24.53% |
| 2013-12-31 | $64.70M | $264.06M | (m) | 24.50% |
| 2013-09-30 | $62.62M | $260.27M | (m) | 24.06% |
| 2013-06-30 | $61.42M | $255.87M | (m) | 24.01% |
| 2013-03-31 | $61.11M | $252.60M | (m) | 24.19% |
| 2012-12-31 | $62.59M | $252.09M | (m) | 24.83% |
| 2012-09-30 | (m) | $250.07M | (m) | (m) |
| 2012-06-30 | (m) | $246.89M | (m) | (m) |
| 2012-03-31 | (m) | $242.85M | (m) | (m) |
| 2011-12-31 | (m) | $237.01M | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $211.23M | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | $201.41M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |